Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) - Total Liabilities

Latest as of March 2026: CN¥588.54 Million CNY ≈ $86.12 Million USD

Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has total liabilities worth CN¥588.54 Million CNY (≈ $86.12 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shenzhen Bioeasy Biotechnology Co. Ltd. - Total Liabilities Trend (2016–2025)

This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Shenzhen Bioeasy Biotechnology Co. Ltd. to evaluate short-term liquidity relative to the company's equity base.

Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Shinsegae Inte KO:031430	Korea	₩567.22 Billion
Viking Line Abp HE:VIK1V	Finland	€277.00 Million
Southern States Bancshares Inc NASDAQ:SSBK	USA	$2.56 Billion
Belo Sun Mining Corp. TO:BSX	Canada	CA$2.05 Million
Entree Resources Ltd TO:ETG	Canada	CA$83.39 Million
Zhejiang Golden Eagle Co Ltd SHG:600232	China	CN¥910.56 Million
3D Systems Corporation NYSE:DDD	USA	$279.18 Million
Panda Dairy Corp SHE:300898	China	CN¥92.42 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Shenzhen Bioeasy Biotechnology Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shenzhen Bioeasy Biotechnology Co. Ltd. market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.29	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.40	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Bioeasy Biotechnology Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)

The table below shows the annual total liabilities of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥616.87 Million ≈ $90.27 Million	+5.10%
2024-12-31	CN¥586.92 Million ≈ $85.89 Million	+15.62%
2023-12-31	CN¥507.61 Million ≈ $74.28 Million	+59.75%
2022-12-31	CN¥317.75 Million ≈ $46.50 Million	+54.29%
2021-12-31	CN¥205.94 Million ≈ $30.14 Million	+98.20%
2020-12-31	CN¥103.90 Million ≈ $15.20 Million	+13.75%
2019-12-31	CN¥91.35 Million ≈ $13.37 Million	+23.08%
2018-12-31	CN¥74.22 Million ≈ $10.86 Million	+25.38%
2017-12-31	CN¥59.19 Million ≈ $8.66 Million	-12.73%
2016-12-31	CN¥67.83 Million ≈ $9.93 Million	--

About Shenzhen Bioeasy Biotechnology Co. Ltd.

SHE:300942 China Biotechnology

Market Cap

$360.99 Million

CN¥2.47 Billion CNY

Market Cap Rank

#14050 Global

#4205 in China

Share Price

CN¥6.09

Change (1 day)

-3.03%

52-Week Range

CN¥6.09 - CN¥13.82

All Time High

CN¥40.28